Tiziana Life Sciences Ltd (TLSA) Operating cash flow 2017–2024
Tiziana Life Sciences Ltd (TLSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.5MFY2024 · since FY2017: -$7.5M → -$1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.5M | +90.3% |
| FY2023 | -$15.7M | +20.0% |
| FY2022 | -$19.6M | +9.9% |
| FY2021 | -$21.8M | -92.0% |
| FY2020 | -$11.3M | -66.8% |
| FY2019 | -$6.8M | -47.7% |
| FY2018 | -$4.6M | +38.9% |
| FY2017 | -$7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSA financial trends
TLSA RevenueTLSA Net incomeTLSA Net marginTLSA Gross profitTLSA Gross marginTLSA Operating incomeTLSA Operating marginTLSA Free cash flowTLSA Capital expendituresTLSA Return on equityTLSA Stock buybacksTLSA Dividends paidTLSA Total assetsTLSA Total liabilitiesTLSA Shareholders’ equityTLSA overview →